Treatment Action Campaign v Rath and Others (2807/05) [2006] ZAWCHC 8; [2007] 2 All SA 439 (C); 2007 (4) SA 563 (C) (3 March 2006)

Treatment Action Campaign v Rath and Others (2807/05) [2006] ZAWCHC 8; [2007] 2 All SA 439 (C); 2007 (4) SA 563 (C) (3 March 2006)

The court found that while robust public debate on the efficacy of anti-retroviral drugs is protected by freedom of expression, the respondents' specific allegations that the applicant is a front for pharmaceutical companies and is funded by them are defamatory and unsupported by evidence. The applicant demonstrated a prima facie right to protection of its reputation, and the harm caused by such statements could not be remedied by damages. The court held that the limited restraint on free speech imposed by the interim interdict is justified to prevent irreparable harm to the applicant's mission and reputation, without unduly restricting legitimate public debate. The balance of...

Citation
[2006] ZAWCHC 8
Parties
Applicant: Treatment Action Campaign; Respondent: Matthias Rath; Respondent: Dr Rath Health Foundations; Respondent: Traditional Healers Organisation
Court
Western Cape High Court, Cape Town
Jurisdiction
South Africa
Judgment Date
3 March 2006
Case Number
2807/05
Procedural Posture
Urgent Application / Interim Interdict Application Prior to Trial
Outcome
Interim interdict granted restraining respondents from publishing specified defamatory statements pending final determination of the main action.
Judges
Desai, Louw, Moosa
Legal Topics
Freedom of Expression, Defamation, Interim Interdict, Balancing of Rights, Human Dignity

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 5 Authorities cited 8 Party arguments 2 Amounts and remedies 2
Sign in to unlock

Parties

Treatment Action Campaign

Applicant

Matthias Rath

Respondent

Dr Rath Health Foundations

Respondent

Traditional Healers Organisation

Respondent

Procedural Posture

Urgent Application / Interim Interdict Application Prior to Trial

  1. 1 Whether the respondents' statements alleging that the applicant is a front for pharmaceutical companies are defamatory.
  2. 2 Whether the applicant is entitled to an interim interdict restraining publication of such statements pending trial.
  3. 3 How to balance the constitutional rights to freedom of expression and dignity/reputation in the context of public debate on HIV/AIDS.

Ratio Decidendi

The court found that while robust public debate on the efficacy of anti-retroviral drugs is protected by freedom of expression, the respondents' specific allegations that the applicant is a front for pharmaceutical companies and is funded by them are defamatory and unsupported by evidence. The applicant demonstrated a prima facie right to protection of its reputation, and the harm caused by such statements could not be remedied by damages. The court held that the limited restraint on free speech imposed by the interim interdict is justified to prevent irreparable harm to the applicant's mission and reputation, without unduly restricting legitimate public debate. The balance of...

Court Disposition

Interim interdict granted restraining respondents from publishing specified defamatory statements pending final determination of the main action.

Orders

  • The respondents are interdicted, pending the final determination of an action instituted by the applicant, from publishing any statement alleging that the applicant is a front for pharmaceutical companies or the pharmaceutical industry, or the 'Trojan horse' or 'running dog' of that industry.
  • The respondents are interdicted from publishing any statement alleging that the applicant is funded by pharmaceutical companies or the pharmaceutical industry.